These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26437225)

  • 1. Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
    Shen JP; Srivas R; Gross A; Li J; Jaehnig EJ; Sun SM; Bojorquez-Gomez A; Licon K; Sivaganesh V; Xu JL; Klepper K; Yeerna H; Pekin D; Qiu CP; van Attikum H; Sobol RW; Ideker T
    Oncotarget; 2015 Nov; 6(34):35755-69. PubMed ID: 26437225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of Rad17/Mec3/Ddc1 and its partial complexes in the DNA damage checkpoint.
    Majka J; Burgers PM
    DNA Repair (Amst); 2005 Sep; 4(10):1189-94. PubMed ID: 16137930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction between checkpoint genes RAD9, RAD17, RAD24, and RAD53 involved in the determination of yeast Saccharomyces cerevisiae sensitivity to ionizing radiation].
    Koltovaia NA; Nikulushkina IuV; Kadyshevskaia EIu; Roshchina MP; Devin AB
    Genetika; 2008 Aug; 44(8):1045-55. PubMed ID: 18825953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a complex containing Rad17, Mec3, and Ddc1 in the yeast DNA damage checkpoint pathway.
    Kondo T; Matsumoto K; Sugimoto K
    Mol Cell Biol; 1999 Feb; 19(2):1136-43. PubMed ID: 9891048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Saccharomyces cerevisiae RAD17 and CHK1 checkpoint genes in the repair of double-strand breaks in cycling cells.
    Bracesco N; Candreva EC; Keszenman D; Sánchez AG; Soria S; Dell M; Siede W; Nunes E
    Radiat Environ Biophys; 2007 Nov; 46(4):401-7. PubMed ID: 17624540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA replication checkpoint control of Wee1 stability by vertebrate Hsl7.
    Yamada A; Duffy B; Perry JA; Kornbluth S
    J Cell Biol; 2004 Dec; 167(5):841-9. PubMed ID: 15583029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.
    Chilà R; Basana A; Lupi M; Guffanti F; Gaudio E; Rinaldi A; Cascione L; Restelli V; Tarantelli C; Bertoni F; Damia G; Carrassa L
    Oncotarget; 2015 Feb; 6(5):3394-408. PubMed ID: 25428911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interaction between checkpoint genes RAD9, RAD17, RAD24, and RAD53 involved in the determination of yeast Saccharomyces cerevisiae sensitivity to ionizing radiation].
    Koltovaia NA; Nikulushkina IuV; Poshchina MP; Devin AB
    Genetika; 2008 Jun; 44(6):761-70. PubMed ID: 18727386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis.
    Mak JP; Man WY; Ma HT; Poon RY
    Oncotarget; 2014 Nov; 5(21):10546-57. PubMed ID: 25301733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading.
    Hauge S; Naucke C; Hasvold G; Joel M; Rødland GE; Juzenas P; Stokke T; Syljuåsen RG
    Oncotarget; 2017 Feb; 8(7):10966-10979. PubMed ID: 28030798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation.
    Davies KD; Cable PL; Garrus JE; Sullivan FX; von Carlowitz I; Huerou YL; Wallace E; Woessner RD; Gross S
    Cancer Biol Ther; 2011 Nov; 12(9):788-96. PubMed ID: 21892012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Rad9-Hus1-Rad1 and TopBP1 activates ATR-ATRIP and promotes TopBP1 recruitment to sites of UV-damage.
    Ohashi E; Takeishi Y; Ueda S; Tsurimoto T
    DNA Repair (Amst); 2014 Sep; 21():1-11. PubMed ID: 25091155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.
    Tse AN; Sheikh TN; Alan H; Chou TC; Schwartz GK
    Mol Pharmacol; 2009 Jan; 75(1):124-33. PubMed ID: 18820127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.
    Mak JP; Man WY; Chow JP; Ma HT; Poon RY
    Oncotarget; 2015 Aug; 6(25):21074-84. PubMed ID: 26025928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutant allele of the chromatin-bound fission yeast checkpoint protein Rad17 separates the DNA structure checkpoints.
    Griffiths D; Uchiyama M; Nurse P; Wang TS
    J Cell Sci; 2000 Mar; 113 ( Pt 6)():1075-88. PubMed ID: 10683155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
    Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
    Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo.
    Chaudhuri L; Vincelette ND; Koh BD; Naylor RM; Flatten KS; Peterson KL; McNally A; Gojo I; Karp JE; Mesa RA; Sproat LO; Bogenberger JM; Kaufmann SH; Tibes R
    Haematologica; 2014 Apr; 99(4):688-96. PubMed ID: 24179152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
    Restelli V; Chilà R; Lupi M; Rinaldi A; Kwee I; Bertoni F; Damia G; Carrassa L
    Oncotarget; 2015 Nov; 6(35):37229-40. PubMed ID: 26439697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways.
    Aarts M; Bajrami I; Herrera-Abreu MT; Elliott R; Brough R; Ashworth A; Lord CJ; Turner NC
    Mol Cancer Ther; 2015 Apr; 14(4):865-76. PubMed ID: 25673822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma.
    Derenzini E; Agostinelli C; Imbrogno E; Iacobucci I; Casadei B; Brighenti E; Righi S; Fuligni F; Ghelli Luserna Di Rorà A; Ferrari A; Martinelli G; Pileri S; Zinzani PL
    Oncotarget; 2015 Mar; 6(9):6553-69. PubMed ID: 25544753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.